Atlas Trials

The Role of Endogenous GLP-1 (Glycolipoprotein) in Regulating Glucose Stimulated Brain Activity

Clinical trial NCT01918566 · COMPLETED

Trial details

NCT number
NCT01918566
Sponsor
University Hospital, Basel, Switzerland
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Exploratory Behavior
Start date
2012-03-01
Primary completion
2013-03-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.